Immuron Limited
IMRN
|
$2.32
-5.31%
-5.6%
26K
|
Health Technology
(0.0% 1d) (-9.8% 1m) (10.0% 1y) (0.0% 2d) (-4.1% 3d) (-10.8% 7d) (1917.45% volume)
Earnings Calendar:
Market Cap: $ 13,223,905
http://www.immuron.com
Sec Filling | Patents | 11 employees
(AU) Immuron Ltd. engages in the research and development of oral immunotherapy, and product sales which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the following segments: Research and Development, and HyperImmune Products.The Research and Development segment involves the R&D projects performed in Australia, Israel, and United States. The HyperImmune Products segment comprises of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994 and is headquartered in Carlton, Australia.
antibody immunotherapy israel treatment
add to watch list Paper trade email alert is off
Press-releases
Immuron to host Live Virtual Event
Published: 2024-04-15 (Crawled : 10:00) - globenewswire.com
IMRN | $2.32 -5.31% -5.6% 26K
|
Health Technology
|
| O: 3.4%
H: 0.0%
C: -5.47%
Immuron Travelan® sales continued strong growth
Published: 2024-04-10 (Crawled : 10:00) - globenewswire.com
IMRN | $2.32 -5.31% -5.6% 26K
|
Health Technology
|
| O: 7.08%
H: 4.75%
C: 1.36%
travelan sales growth
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
Published: 2024-03-07 (Crawled : 11:00) - globenewswire.com
IMRN | $2.32 -5.31% -5.6% 26K
|
Health Technology
|
| O: 104.23%
H: 76.85%
C: 35.01%
travelan positive trials results
Immuron Presentation Australian Biologics Festival 2024
Published: 2024-02-21 (Crawled : 11:00) - globenewswire.com
IMRN | $2.32 -5.31% -5.6% 26K
|
Health Technology
|
| O: -0.01%
H: 1.67%
C: -2.77%
presentation
Immuron achieves record Travelan® sales
Published: 2024-02-13 (Crawled : 11:00) - globenewswire.com
IMRN | $2.32 -5.31% -5.6% 26K
|
Health Technology
|
| O: 3.67%
H: 1.06%
C: 1.06%
travelan sales
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
Published: 2024-02-08 (Crawled : 11:00) - globenewswire.com
IMRN | $2.32 -5.31% -5.6% 26K
|
Health Technology
|
| O: -1.67%
H: 0.56%
C: 0.56%
presentation
Immuron achieves record half yearly Travelan® sales
Published: 2024-01-16 (Crawled : 11:00) - globenewswire.com
IMRN | $2.32 -5.31% -5.6% 26K
|
Health Technology
| Email alert
Add to watchlist
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
| Email alert
Add to watchlist
travelan sales
Immuron Clinical Trials Update
Published: 2023-12-22 (Crawled : 11:00) - globenewswire.com
IMRN | $2.32 -5.31% -5.6% 26K
|
Health Technology
|
| O: 2.82%
H: 0.0%
C: -2.74%
update trials
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study
Published: 2023-12-04 (Crawled : 11:00) - globenewswire.com
IMRN | $2.32 -5.31% -5.6% 26K
|
Health Technology
|
| O: 3.41%
H: 0.0%
C: -2.52%
study
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
Published: 2023-11-28 (Crawled : 12:00) - globenewswire.com
IMRN | $2.32 -5.31% -5.6% 26K
|
Health Technology
|
| O: 1.04%
H: 7.18%
C: 4.62%
presentation
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10